financetom
Business
financetom
/
Business
/
Thai investigation clears BYD over discounts, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thai investigation clears BYD over discounts, sources say
Nov 29, 2024 3:36 AM

By Panarat Thepgumpanat and Chayut Setboonsarng

BANGKOK (Reuters) - Thailand's consumer watchdog has cleared Chinese EV maker BYD of wrongdoing over its discount practices that have prompted complaints from BYD owners and a subsequent probe by the agency, two sources familiar with the matter said.

The government in July launched a probe into BYD's local distributor, Rever Automotive, after a complaint alleged they had asserted vehicle prices would rise after a discount campaign ended, but instead they cut prices further soon after -- by as much as 340,000 baht ($9,000).

BYD holds a 20% stake in Rever.

Such practices had misled consumers and left many feeling short-changed, buyers had said in their complaint.

The probe by the Consumer Protection Board concluded that BYD's discounting did not violate advertising law, said one of the sources who has direct knowledge of the matter.

"The price cuts announced coincided with actual discounts," the person said. The sources declined to be named because the information is not public yet.

The Consumer Protection Board did not respond to a Reuters request for comment.

The board, however, fined its local distributor Rever Automotive and one of its executives a total of 120,000 baht for a separate infraction of not disclosing the prices of giveaways, senior board official, Thitinan Singha, told Reuters.

Rever and BYD did not respond to requests for comment.

A customer backlash against its vehicles in Thailand, one of BYD's biggest overseas markets, comes as the auto sector is grappling with a sharp decline in consumer demand for vehicles there due to rising household debt.

On Thursday, BYD announced another price reduction of its Atto 3 and Seal models by as much as 400,000 baht ($11,700).

In China, BYD has asked its suppliers to cut their prices, a local media reported, in a sign that a brutal price war is set to escalate in the world's largest auto market.

Most Thai customers want to be compensated with the difference from the discounted price, said senior agency official Passakorn Thapmongkol.

Nuntipak Tarnvimonkarn, who bought a BYD vehicle in 2022 that has seen its sale price drop by over 400,000 baht, said that he and about ten others were planning further legal action.

In an attempt to appease disgruntled owners, BYD has offered a 50,000 baht cash-back programme for new vehicle purchases and free use of its charging stations.

($1 = 34.2700 baht)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gerdau Q3 Earnings Decline, Net Sales Increase
Gerdau Q3 Earnings Decline, Net Sales Increase
Oct 31, 2025
03:41 AM EDT, 10/31/2025 (MT Newswires) -- Gerdau ( GGB ) reported Q3 earnings Thursday of 0.54 Brazilian real ($0.10) per share, down from 0.64 real a year earlier. Analysts polled by FactSet expected 0.61 real. Net sales for the quarter ended Sept. 30 were 17.98 billion reais, up from 17.38 billion reais a year earlier. Analysts surveyed by FactSet...
Healthcare Realty Q3 Normalized FFO Rises, Rental Income Revenue Falls
Healthcare Realty Q3 Normalized FFO Rises, Rental Income Revenue Falls
Oct 31, 2025
03:25 AM EDT, 10/31/2025 (MT Newswires) -- Healthcare Realty Trust ( HR ) reported Q3 normalized funds from operations late Thursday of $0.41 per diluted share, up from $0.39 a year earlier. Analysts polled by FactSet expected $0.40. Rental income revenue for the quarter ended Sept. 30 was $287.4 million, down from $306.5 million a year ago. Analysts surveyed by...
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Oct 31, 2025
By Bhanvi Satija LONDON (Reuters) -Metsera ( MTSR ) has become the obesity drug market's hottest ticket. The New York-based biotech is at the centre of a bidding war between Novo Nordisk and Pfizer ( PFE ), both vying for access to its pipeline of experimental treatments as competition intensifies in the booming $150 billion weight-loss drug market. Metsera's (...
Uber to invest $200 mln in Turkey technology centre, ministry says
Uber to invest $200 mln in Turkey technology centre, ministry says
Oct 31, 2025
ANKARA, Oct 31 (Reuters) - Uber ( UBER ) will invest $200 million over five years in a software and technology development centre in Istanbul, Turkey's Industry and Technology Ministry said on Friday. In a statement, the ministry said the centre will be Uber's ( UBER ) fourth such facility outside the United States, following ones in Brazil, India and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved